Clinical Trials Logo

Clinical Trial Summary

Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability


Clinical Trial Description

Osteomalacia describes a bone disorder in adults that is usually caused by long-term vitamin D deficiency. Osteomalacia, a metabolic bone disease characterized by impaired mineralization of the bone matrix.Not a single laboratory finding is specific to osteomalacia.The relationship between collagen and prolidase activity has been observed during fibrotic processes, where an increase in prolidase activity is accompanied by an increase in tissue collagen deposition. It has also been suggested that serum activity is increased in metabolic bone diseases.Leptin is a 16 kDa peptide hormone. It is a member of the long chain helical cytokine family, which is mainly produced by fat cells and proportional to the size of the stored fat. Leptin affects bone remodeling by reducing the activity of osteoclasts and thus participates in the pathogenesis of osteoporosis. In the light of these studies, the investigators planned our study according to the clinical significance of serum prolidase activity in osteomalacia and the place of leptin in osteomalacia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05716750
Study type Interventional
Source University of Beykent
Contact
Status Not yet recruiting
Phase N/A
Start date February 15, 2023
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT02252679 - Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders
Completed NCT02548520 - Maternal and Infant Vitamin Status During the First Nine Months of Infant Life N/A
Recruiting NCT00024804 - A Natural History Study of Bone and Mineral Disorders
Terminated NCT01748812 - Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets) Phase 1
Recruiting NCT04045834 - Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Active, not recruiting NCT03736564 - Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia Phase 1/Phase 2
Completed NCT01025128 - Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density Phase 4
Completed NCT02084693 - COMPREHENSIVE® REVERSE SHOULDER Mini BasePlate
Completed NCT00099762 - Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic Osteomalacia N/A
Completed NCT00001242 - Studies of States With Resistance to Vitamin D and Parathyroid Hormone
Completed NCT04841213 - Dental Implants Rehabilitation in Patients With Vitamin D3 Imbalance N/A
Completed NCT01102751 - Serum FGF-23 and Vitamin D Deficiency N/A